m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.

Authors:
Elena Huerta-Ramos
Elena Huerta-Ramos
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
Spain
Susana Ochoa
Susana Ochoa
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
Spain
Mireia Rabella
Mireia Rabella
Hospital de la Santa Creu i Sant Pau
Barcelona | Spain

Actas Esp Psiquiatr 2017 Nov 1;45(6):277-89. Epub 2017 Nov 1.

Parc Sanitari Sant Joan de Déu, Barcelona, Spain Instituto de Salud Carlos III, Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain Catalan Group in Women's Mental Health Research (GTRDSM), Barcelona, Spain.

Background: Despite the theoretical potential of m-health solutions in the treatment of patients with schizophrenia, there remains a lack of technological solutions in daily practice. The aim of this study was to measure the receptivity of patients, informal carers, and clinicians to an integral intervention model focused on patients with persistent positive symptoms: Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia (m-RESIST).

Methods: A qualitative study of the needs and acceptability of outpatients with treatment-resistant schizophrenia was carried out in Parc Sanitari Sant Joan de Déu (Barcelona). We analyzed the opinions of patients, informal carers, and clinicians concerning the services initially thought to be part of the solution. Five focus groups and eight interviews were carried out, using discourse analysis as the analytical approach.

Results: A webpage and a virtual forum were perceived as suitable to get reliable information on both the disease and support. Data transmission service, online visits, and instant messages were evaluated as ways to improve contact with clinicians. Alerts were appreciated as reminders of daily tasks and medical appointments. Avoiding stressful situations for outpatients, promoting an active role in the management of the disease, and maintaining human contact with clinicians were the main suggestions for improving the effectiveness of the solution.

Conclusions: Positive acceptance of m-RESIST services is related to its usefulness in meeting user needs, its capacity to empower them, and the possibility of maintaining human contact.
November 2017
15 Reads

Publication Analysis

Top Keywords

patients informal
8
human contact
8
informal carers
8
contact clinicians
8
qualitative study
8
carers clinicians
8
maintaining human
8
patients
6
focus groups
4
groups interviews
4
carried discourse
4
interviews carried
4
discourse analysis
4
analytical approachresults
4
suitable reliable
4
reliable disease
4
disease support
4
support data
4
perceived suitable
4
forum perceived
4

Similar Publications

Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study.

JMIR Mhealth Uhealth 2016 Sep 28;4(3):e112. Epub 2016 Sep 28.

Parc Sanitari Sant Joan de Déu, CIBERSAM G11, Barcelona, Spain.

Background: Despite the theoretical potential of mHealth solutions in the treatment of patients with schizophrenia, there remains a lack of technological tools in clinical practice.

Objective: The aim of this study was to measure the receptivity of patients, informal carers, and clinicians to a European integral intervention model focused on patients with persistent positive symptoms: Mobile Therapeutic Attention for Patients with Treatment-Resistant Schizophrenia (m-RESIST).

Methods: Before defining the system requirements, a qualitative study of the needs of outpatients with treatment-resistant schizophrenia was carried out in Spain, Israel, and Hungary. Read More

View Article
September 2016

Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.

BMJ Open 2018 Jul 16;8(7):e021346. Epub 2018 Jul 16.

Department of Psychiatry, Biomedical Research Institute Sant Pau (IIB-SANT PAU), Hospital Santa Creu i Sant Pau; Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Introduction: Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia. In the European Union, approximately 40% of people with schizophrenia have TRS. Factors such as the persistence of positive symptoms or higher risk of comorbidities leave clinicians with a complex scenario when treating these patients. Read More

View Article
July 2018

Providing services to families of persons with schizophrenia: present and future.

Authors:
Lisa Dixon

J Ment Health Policy Econ 1999 Mar;2(1):3-8

Center for Mental Health Services Research, University of Maryland School of Medicine, 701 West Pratt Street, Baltimore, MD 21201, USA,

BACKGROUND: The important role of families and other caregivers in the lives of adults with schizophrenia is well documented. Persons with schizophrenia frequently live with their families of origin, and the vast majority have regular family contact. Families of persons with schizophrenia have also been demonstrated to have significant needs. Read More

View Article
March 1999

Mobile phone messaging for facilitating self-management of long-term illnesses.

Cochrane Database Syst Rev 2012 Dec 12;12:CD007459. Epub 2012 Dec 12.

Gephyra IHC, Amsterdam, Netherlands.

Background: Long-term illnesses affect a significant proportion of the population in developed and developing countries. Mobile phone messaging applications, such as Short Message Service (SMS) and Multimedia Message Service (MMS), may present convenient, cost-effective ways of supporting self-management and improving patients' self-efficacy skills through, for instance, medication reminders, therapy adjustments or supportive messages.

Objectives: To assess the effects of mobile phone messaging applications designed to facilitate self-management of long-term illnesses, in terms of impact on health outcomes and patients' capacity to self-manage their condition. Read More

View Article
December 2012